Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jan 5;79(2):14-15.
doi: 10.1093/ajhp/zxab364.

Avoiding cost avoidance

Brian Murray  1 , Andrea Sikora Newsome  2   3
Affiliations
Comment

Avoiding cost avoidance

Brian Murray et al. Am J Health Syst Pharm. .
No abstract available

Keywords: critical care; pharmacy; value.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Why metrics matter for critical care pharmacist-to-patient ratios. These 2 figures depict how metric achievement (top) and metric achievement as a function of cost or return on investment (bottom) change based on the number of full-time employees (FTE) and potential pharmacist-to-patient ratios. Ultimately, evaluation of pharmacist productivity (and associated return on investment) is based on the specific metric of interest. For example, with cost avoidance, this goal may be achieved with the addition of a single pharmacist, meaning that any further resources will actually reduce return on investment (blue lines). However, if metrics such as scholarly activities as outlined in the position statement are used, the return on investment may increase for each additional employee (orange lines).
See this image and copyright information in PMC

Comment in

  • Response to Murray et al.
    Erstad BL. Erstad BL. Am J Health Syst Pharm. 2022 Jan 5;79(2):16. doi: 10.1093/ajhp/zxab357. Am J Health Syst Pharm. 2022. PMID: 34487156 No abstract available.

Comment on

References

    1. Erstad BL. Justification of the value of critical care pharmacists: still a work in progress? Am J Health-Syst Pharm. 2020;77(22):1906-1909. - PubMed
    1. Hammond DA, Gurnani PK, Flannery AH, et al. . Scoping review of interventions associated with cost avoidance able to be performed in the intensive care unit and emergency department. Pharmacotherapy. 2019;39(3):215-231. - PubMed
    1. Haas CE, Vermeulen LC.. Caution warranted when torturing data until they confess. J Am Coll Clin Pharm. 2019;2(6):606-607.
    1. Vermeulen LC, Haas CE. Drs. Haas and Vermeulen reply to Drs. Hammond and Rech. J Am Coll Clin Pharm. 2020;3(2):548-549.
    1. Lat I, Paciullo C, Daley MJ, et al. . Position paper on critical care pharmacy services: 2020 update. Crit Care Med. 2020;48(9):e813-e834. - PubMed